myokinesnonalcoholic fatty liver diseasenonalcoholic steatohepatitisstellakines[This corrects the article DOI: 10.3389/fendo.2022.1007944.].Bing YangLiqing LuDongmei ZhouWei FanLucía Barbier-TorresJustin SteggerdaHeping YangXi YangFrontiers in Endocrinology...
de Piano A, Prado WL, Caranti DA, Siqueira KO, Stella SG, Lofrano M, et al. Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2007; 44: 446-452.de Piano A, Prado WL, Caranti DA, et al. Metabolic and nutritional ...
Mitochondrial function is impaired in patients with nonalcoholic steatohepatitis (NASH) as assessed in vivo by C-13-ketoisocaproate (KICA) breath testdoi:10.1016/S0168-8278(05)82084-7Portincasa, PGrattagliano, ILauterburg, BHPalmieri, VO
AIM:To evaluate the association of nonalcoholic fatty liver disease(NAFLD)with acute ischemic stroke severity and in-hospital outcome.METHODS:We prospectively studied all patients who were admitted in our Department with acute ischemic stroke between September 2010 and August 2012(n=415;39.5%males,...
Conclusions: S. sonchifolius roots can ameliorate non-alcoholic fatty liver disease by improving oxidative stress and liver injury.doi:10.4103/2221-1691.267637Alemán, MarianoSánchez, SaraHonoré, StellaAsian Pacific Journal of Tropical Biomedicine
at a temp. low enough to prevent fermentation occurring. (I) is either a material which could be fermented to alcohol by yeast, e.g. must, grape or other fruit juice or a non-fermentable material, e.g. whey. In either case it may be obtd. by diln. of a concentrate.SCHUR F...
sonchifolius roots can ameliorate non-alcoholic fatty liver disease by improving oxidative stress and liver injury.亚太热带生物医学杂志(英文版)doi:10.4103/2221-1691.267637MarianoNicolásAlemánSaraSerafinaSánchezStellaMarisHonoré
at a temp. low enough to prevent fermentation occurring. (I) is either a material which could be fermented to alcohol by yeast, e.g. must, grape or other fruit juice or a non-fermentable material, e.g. whey. In either case it may be obtd. by diln. of a concentrate.F * SCHUR...
Stellavato A, Lamberti M, Pirozzi AV, et al. Myclobutanil worsens nonalcoholic fatty liver disease: an in vitro study of toxicity and apoptosis on HepG2 cells. Toxicol Lett. 2016;262:100-104.Stellavato A, Lamberti M, Pirozzi AV, de Novellis F, Schiraldi C. Myclobutanil worsens ...
Objective: Non-alcoholic fatty liver disease (NAFLD) and metabolic associated fatty liver disease (MAFLD) are a growing health problem, with a growing prevalence due to its association with metabolic syndrome and diabetes. It is known to be a risk factor for the development of cirrhosis and ...